ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Renal Allograft Rejection: New Paradigms in the T Cell Landscape Revealed by Single Cell RNAseq Analysis

T. Shi1, A. Burg1, K. Roskin2, J. Rush3, B. Haraldsson3, A. Shields4, R. Alloway4, E. Woodle5, D. Hildeman1

1Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Novartis Pharmaceuticals AG, Basel, Switzerland, 4Internal Medicine, University of Cincinnati, Cincinnati, OH, 5Surgery, University of Cincinnati, Cincinnati, OH

Meeting: 2022 American Transplant Congress

Abstract number: 372

Keywords: Genomics, T cell clones, T cell receptors (TcR), Tissue-specific

Topic: Basic Science » Basic Science » 02 - Acute Rejection

Session Information

Session Name: Acute Rejection

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 6, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 6:00pm-6:10pm

Location: Hynes Room 309

*Purpose: Defining the T cell landscape in renal allograft rejection (RAR) transcriptomically at the single cell level remains to be achieved. The purpose of the present study was to define distinct T cell populations involved in RAR.

*Methods: Renal allograft biopsy samples along with paired urine samples were collected from 9 patients during for cause biopsy procedures from kidney transplant patients. 5’ single cell RNA sequencing (scRNAseq) with paired TCRα/β sequencing (TCRseq) was performed on urine and biopsy samples that were digested at 4C using psychrophilic enzymes. Whole transcriptomic and TCR data was analyzed by Seurat and Loupe V(D)J browser, and individual T cell CDR3α/β clonotypes were identified. Expanded clones were defined as > 2 cells and 0.5% of T cell barcodes identified with identical CDR3α/β sequences.

*Results: Samples obtained at the time of RAR diagnosis revealed an impressive degree of TCR restriction (avg. 14 expanded CD8+ clones/patient). Transcriptomic profiles of the expanded clones included markers associated with effector function, consistent with an ongoing alloresponse. To assess the possibility that the limited number of expanded clones was due to sampling bias, we analyzed 4 patients who had subsequent biopsies following RAR diagnosis. The subsequent biopsies demonstrated that >80% of the same clonally expanded T cells remained present (Fig 1a). Similarly, biopsy-paired urine samples demonstrated a substantial overlap in TCR clones with biopsy samples (Fig 1b). Interestingly, in patients with rejection reversal, clonal populations were largely eliminated and replaced with memory phenotype CD8+ T cells. In contrast, in patients with treatment resistant rejection, clonal populations were maintained. However, their gene expression profiles changed in response to anti-rejection therapies (Fig 2).

*Conclusions: 1) RAR is characterized by a remarkably limited number of distinct CD8+ T cell clones, 2) CD8+ T cell clones persist in ongoing rejection and disappear with rejection resolution, 3) CD8+ T cell clones isolated from simultaneous urine samples are highly similar to those isolated from biopsies, and 4) transcriptional profiles of clonally expanded cells shift in response to anti- rejection treatment.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Shi T, Burg A, Roskin K, Rush J, Haraldsson B, Shields A, Alloway R, Woodle E, Hildeman D. Renal Allograft Rejection: New Paradigms in the T Cell Landscape Revealed by Single Cell RNAseq Analysis [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/renal-allograft-rejection-new-paradigms-in-the-t-cell-landscape-revealed-by-single-cell-rnaseq-analysis/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences